Jeff Yass’s GlucoTrack GCTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.36K Buy
+10,546
New +$6.61K ﹤0.01% 13213
2024
Q2
Sell
-2
Closed -$4.52K 12439
2024
Q1
$4.52K Buy
+2
New +$3.14K ﹤0.01% 11959
2023
Q2
Sell
-3
Closed -$5.62K 12441
2023
Q1
$5.62K Buy
3
+1
+50% +$5.89K ﹤0.01% 12293
2022
Q4
$15.5K Buy
+2
New +$20.5K ﹤0.01% 11842
2022
Q1
Sell
-2
Closed -$48K 13339
2021
Q4
$48K Buy
+2
New +$46.5K ﹤0.01% 12569

Other funds holding GCTK

Jeff Yass's GCTK Position: Q2 2026 in Review

Jeff Yass opened a new position in GlucoTrack (GCTK) in Q2 2026: 10,546 shares worth $3.36K. The stake represents ﹤0.01% of the portfolio and ranks #13213 among its holdings. This is a return to the name: Jeff Yass previously reported a position in GCTK as recently as Q1 2024.

Jeff Yass first reported a position in GCTK in Q4 2021 and has held it in 5 quarters since. The position peaked at $48K in Q4 2021. 19 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Jeff Yass held 10,546 shares of GlucoTrack worth $3.36K as of Q2 2026.
  • GlucoTrack was a new Jeff Yass position in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13213 holding.
  • Jeff Yass first reported a position in GlucoTrack in Q4 2021 and has held it in 5 quarters since.
  • Jeff Yass's GlucoTrack position peaked at $48K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.